Cannara Biotech Balance Sheet

Financials in millions CAD. Fiscal year is September - August.

Millions CAD. Fiscal year is Sep - Aug.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '25 Nov 30, 2025	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021
Cash & Equivalents	16.52	14.36	6.62	4.27	12.11	8.16
Cash & Short-Term Investments	16.52	14.36	6.62	4.27	12.11	8.16
Cash Growth	60.97%	116.91%	55.02%	-64.75%	48.48%	4.99%
Accounts Receivable	15.22	14.11	13.04	10.59	8.62	2.92
Other Receivables	-	-	-	-	-	0.05
Receivables	15.22	14.11	13.04	10.59	8.62	2.97
Inventory	51.97	51.33	40.07	33.77	18.98	7.41
Prepaid Expenses	1.33	2.36	2.85	3.06	1.28	0.71
Other Current Assets	-	-	4.9	-	-	-
Total Current Assets	85.04	82.16	67.47	51.7	40.99	19.25
Property, Plant & Equipment	88.19	86	84.94	89.44	83.4	71.75
Long-Term Accounts Receivable	-	-	-	-	-	0.07
Long-Term Deferred Tax Assets	-	-	1.95	-	-	-
Long-Term Deferred Charges	0.13	0.05	-	0.06	-	-
Other Long-Term Assets	0.49	0.44	0.36	0.33	1.22	0.95
Total Assets	173.84	168.65	154.72	141.52	125.62	92.02
Accounts Payable	12.14	11	9.42	8.12	8.85	6.19
Accrued Expenses	10.1	9.77	7.94	6.86	0.77	0.07
Short-Term Debt	6.76	6.76	6.26	3	-	-
Current Portion of Long-Term Debt	2.11	6.26	2.97	2.97	1.97	0.3
Current Portion of Leases	0.27	0.28	0.28	0.08	0.22	0.23
Current Unearned Revenue	0.13	0.13	0.13	0.16	0.05	0.04
Total Current Liabilities	31.5	34.2	27	21.18	11.86	6.83
Long-Term Debt	25.62	28.17	38.45	39.64	46.19	20.15
Long-Term Leases	0.05	0.11	0.37	0.1	0.02	0.22
Long-Term Unearned Revenue	1.4	0.88	0.94	0.86	0.82	0.71
Long-Term Deferred Tax Liabilities	4.07	3.07	-	-	-	-
Total Liabilities	62.63	66.43	66.77	61.78	58.88	27.91
Common Stock	97.24	89.76	88.52	88.8	83.3	83.21
Additional Paid-In Capital	12.76	12.28	12.33	10.35	9.72	9.41
Retained Earnings	1.22	0.18	-12.9	-19.34	-26.3	-28.61
Comprehensive Income & Other	-	-	-	-0.07	0.02	0.1
Total Common Equity	111.21	102.22	87.95	79.74	66.74	64.12
Shareholders' Equity	111.21	102.22	87.95	79.74	66.74	64.12
Total Liabilities & Equity	173.84	168.65	154.72	141.52	125.62	92.02
Total Debt	34.8	41.58	48.33	45.78	48.39	20.9
Net Cash (Debt)	-18.29	-27.22	-41.71	-41.51	-36.28	-12.74
Net Cash Per Share	-0.20	-0.29	-0.46	-0.46	-0.41	-0.17
Filing Date Shares Outstanding	95.78	94.9	90.02	90.02	87.7	87.65
Total Common Shares Outstanding	94.9	91.43	90.02	90.31	87.7	87.65
Working Capital	53.54	47.96	40.47	30.51	29.13	12.41
Book Value Per Share	1.17	1.12	0.98	0.88	0.76	0.73
Tangible Book Value	111.21	102.22	87.95	79.74	66.74	64.12
Tangible Book Value Per Share	1.17	1.12	0.98	0.88	0.76	0.73
Land	2.33	2.33	2.33	2.45	2.45	2.45
Buildings	77.76	77.76	76.71	75.48	64.3	44.79
Machinery	26.72	25.49	20.65	18.57	14.22	8.47
Construction In Progress	7.21	4.65	4.71	6.73	11.53	21.23

Updated Nov 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.